ArticleBiomedical engineering online2015
Two-hierarchical nonnegative matrix factorization distinguishing the fluorescent targets from autofluorescence for fluorescence imaging.
Article in Biomedical engineering online, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Robust self-supervised denoising of voltage imaging data using CellMincer.bioRxiv : the preprint server for biology · 2024Article
- Article
- Live-cell fluorescence spectral imaging as a data science challenge.Biophysical reviews · 2022Review
- Semi-blind sparse affine spectral unmixing of autofluorescence-contaminated micrographs.Bioinformatics (Oxford, England) · 2020Article
- Robust blind spectral unmixing for fluorescence microscopy using unsupervised learning.PloS one · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNonnegative matrix factorization (NMF) has been used in blind fluorescence unmixing for multispectral in-vivo fluorescence imaging, which decomposes a mixed source data into a set of constituent fluorescence spectra and corresponding concentrations. However, most classical NMF algorithms have ill convergence problems and they always fail to unmix multiple fluorescent targets from background autofluorescence for the sparse acquisition of multispectral fluorescence imaging, which introduces incomplete measurements and severe discontinuities in multispectral fluorescence emissions across the multiple spectral bands.
methodsObserving the spatial distinction between the diffusive autofluorescence and the sparse fluorescent targets, we propose to separate the mixed sparse multispectral data into equality constrained two-hierarchical updating within NMF framework by dividing the concentration matrix of entire endmembers into two hierarchies: the fluorescence targets and the background autofluorescence. Specifically, when updating concentrations of multiple fluorescent targets in the two-hierarchical NMF, we assume that the concentration of autofluorescence is fixed and known, and vice versa. Furthermore, a sparsity constraint is imposed on the concentration matrix components of fluorescence targets only.
resultsSynthetic data sets, in vivo fluorescence imaging data are employed to demonstrate and validate the performance of our approach. The proposed algorithm can achieve more satisfying results of spectral unmixing and autofluorescence removal compared to other state-of-the-art methods, especially for the sparse multispectral fluorescence imaging.
conclusionsThe proposed algorithm can successfully tackle the sparse acquisition and ill-posed problems in the NMF-based fluorescence unmixing through equality constraint along with partial sparsity constraint during two-hierarchical NMF optimization, at which fixing sparsity constrained target fluorescence can make the update of autofluorescence as accurate as possible and vice versa.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.